Coexpression of Vimentin and Cytokeratins in Human Melanoma Cell Lines


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Abstract—Molecular heterogeneity in seven human metastatic melanoma cells lines is revealed using a double immunofluorescent assay by flow cytometry. It is evaluated that quite a small population of cells (up to 10%) expressed only vimentin, the main marker of melanoma. Only epithelial cytokeratins expression is revealed in a significantly greater number of cells (from 25 to 50%). The dominant molecular phenotype (50–80% cells expressed both markers), the coexpression of vimentin and cytokeratins, is identified for the first time. The authors assume that the latter phenotype of melanoma cells may be a molecular marker of the tumor’s aggressiveness and metastatic potential.

About the authors

T. A. Bogush

Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation

Author for correspondence.
Email: tatbogush@mail.ru
Russian Federation, Moscow

S. A. Kaliuzhny

Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation

Email: tatbogush@mail.ru
Russian Federation, Moscow

A. A. Basharina

Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation

Email: tatbogush@mail.ru
Russian Federation, Moscow

E. A. Bogush

Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation

Email: tatbogush@mail.ru
Russian Federation, Moscow

V. Yu. Kirsanov

Sechenov First Moscow State Medical University

Email: tatbogush@mail.ru
Russian Federation, Moscow

V. S. Kosorukov

Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation

Email: tatbogush@mail.ru
Russian Federation, Moscow

O. S. Burova

Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation

Email: tatbogush@mail.ru
Russian Federation, Moscow

M. M. Davydov

Sechenov First Moscow State Medical University

Email: tatbogush@mail.ru
Russian Federation, Moscow

M. A. Baryshnikova

Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation

Email: tatbogush@mail.ru
Russian Federation, Moscow

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2019 Allerton Press, Inc.